Alternatives in plasma gonadotropin and sex steroid levels in obese ovulatory and chronically anovulatory women. 1995

S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
Department of Gynecology and Obstetrics, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil.

OBJECTIVE To evaluate the alterations in plasma gonadotropin and sex steroid levels in obesity. METHODS A study was conducted on 77 obese women, 30 with ovulatory menstrual cycles (group I) and 47 with chronic anovulation (group II), who were compared to 15 women of normal weight and with ovulatory cycles (group C). Obesity was determined on the basis of body mass index. Blood samples were obtained during the follicular phase of the cycle for measurement of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate (DHEAS), estrone (E1) and estradiol (E2). RESULTS Elevated LH, T, A and E1 levels were detected in group II when compared to group I and group C. A levels were also elevated (P < or = .05) in group I when compared to group C. There was no significant difference between the three groups in FSH, PRL, DHEAS or E2 levels. CONCLUSIONS The elevated A levels in group I obese women show that even when ovulating, obese women are hyperandrogenic. This excessive A may activate the aromatizing system in adipose tissue, generating E1. When this occurs, the increase in E1 may trigger an increase in LH, with consequent ovarian hyperstimulation, leading to increased T and anovulatory cycles.

UI MeSH Term Description Entries
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006065 Gonadotropins, Pituitary Hormones secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR) that stimulate gonadal functions in both males and females. They include FOLLICLE STIMULATING HORMONE that stimulates germ cell maturation (OOGENESIS; SPERMATOGENESIS), and LUTEINIZING HORMONE that stimulates the production of sex steroids (ESTROGENS; PROGESTERONE; ANDROGENS). Pituitary Gonadotropins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000858 Anovulation Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy. Anovulations
D012739 Gonadal Steroid Hormones Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE. Gonadal Steroid Hormone,Sex Hormone,Sex Steroid Hormone,Sex Steroid Hormones,Sex Hormones,Hormone, Gonadal Steroid,Hormone, Sex,Hormone, Sex Steroid,Hormones, Gonadal Steroid,Hormones, Sex Steroid,Steroid Hormone, Gonadal,Steroid Hormone, Sex,Steroid Hormones, Gonadal,Steroid Hormones, Sex

Related Publications

S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
January 1991, The Journal of clinical endocrinology and metabolism,
S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
January 1976, British journal of obstetrics and gynaecology,
S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
October 1984, Fertility and sterility,
S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
August 1976, Obstetrics and gynecology,
S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
August 1992, Fertility and sterility,
S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
December 1987, American journal of obstetrics and gynecology,
S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
October 1976, American journal of obstetrics and gynecology,
S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
March 1978, Clinical endocrinology,
S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
September 1988, The Journal of clinical investigation,
S R Unzer, and J E dos Santos, and A C Moreira, and M S Vilanova, and M F de Sá
July 1983, Fertility and sterility,
Copied contents to your clipboard!